AONC AMERICAN ONCOLOGY NETWORK INC

Genesis Cancer and Blood Institute and American Oncology Network Welcome Dr. Tyler Fugere

Genesis Cancer and Blood Institute and American Oncology Network Welcome Dr. Tyler Fugere

Board-certified medical oncologist and hematologist joins physician team

HOT SPRINGS, Ark., Aug. 06, 2025 (GLOBE NEWSWIRE) -- , a partner practice of , is pleased to welcome Board-certified physician , to its physician care team. She joins an experienced group of physicians including Drs. Brad Baltz, Jim Chen, Timothy Webb, Robert Muldoon, Stephen “Fred” Divers, Lynn Cleveland, Lingyi Chen, Sunil Kakadia, and Kristen Sager.



Dr. Fugere is a Board-certified medical oncologist and hematologist. She earned her medical degree from the University of Arkansas for Medical Sciences (UAMS) in Little Rock, where she also completed her internal medicine residency and hematology-oncology fellowship. Originally from Benton, Arkansas, she graduated summa cum laude from Benton High School and later earned her undergraduate degree from Ouachita Baptist University in Arkadelphia.

She is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the National Comprehensive Cancer Network. Dr. Fugere is passionate about providing personalized, patient-centered care in the community setting.

“I’m honored to join Genesis Cancer and Blood Institute,” said . “Genesis has a long-standing reputation for excellence in patient care, and its values align perfectly with my own. I look forward to being part of a team that puts patients first while offering the latest in evidence-based treatment.”

With 10 medical oncologists and five advance practice providers across  Genesis Cancer and Blood Institute offers comprehensive services for cancer diagnosis, treatment, clinical trials, survivorship and patient support—all delivered close to home.

“We’re excited to welcome Dr. Fugere to the Genesis team,” said . “Her knowledge, compassion and dedication to personalized care make her a perfect addition to our group. I know our patients will benefit from her expertise.”

“On behalf of AON, I’m pleased to welcome Dr. Fugere to Genesis and to our national network,” said . “Her commitment to delivering high-quality, community-based care reflects AON’s mission to make exceptional cancer treatment accessible to patients where they live. She will be an invaluable asset to both our team and the patients we serve.”

Dr. Fugure began seeing patients at the Genesis Benton and Little Rock clinics on Aug. 1, 2025.

For more information about AON, visit . To learn more about Genesis Cancer and Blood Institute, visit .

About American Oncology Network

 (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit  or follow us on , ,  and .

About Genesis Cancer and Blood Institute

Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. Brad Baltz, Dr. Jim Chen, Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland, Dr. Lingyi Chen, Dr. Sunil Kakadia, Dr. Kristen Sager, and Dr. Tyler Fugere. Learn more at .

A photo accompanying this announcement is available at



Media Contact:
Karen Riley Sawyer
American Oncology Network
 
EN
06/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AMERICAN ONCOLOGY NETWORK INC

 PRESS RELEASE

Genesis Cancer and Blood Institute and American Oncology Network Welco...

Genesis Cancer and Blood Institute and American Oncology Network Welcome Dr. Tyler Fugere Board-certified medical oncologist and hematologist joins physician team HOT SPRINGS, Ark., Aug. 06, 2025 (GLOBE NEWSWIRE) -- , a partner practice of , is pleased to welcome Board-certified physician , to its physician care team. She joins an experienced group of physicians including Drs. Brad Baltz, Jim Chen, Timothy Webb, Robert Muldoon, Stephen “Fred” Divers, Lynn Cleveland, Lingyi Chen, Sunil Kakadia, and Kristen Sager. Dr. Fugere is a Board-certified medical oncologist and hematologist. She...

 PRESS RELEASE

American Oncology Network Expands Arkansas Presence, Adds Conway Hemat...

American Oncology Network Expands Arkansas Presence, Adds Conway Hematology Oncology to National Network CONWAY, Ark., Aug. 05, 2025 (GLOBE NEWSWIRE) -- , a trusted provider of hematology and oncology care in Conway, Arkansas, is proud to announce it has joined  (AON), one of the nation’s fastest-growing networks of community-based oncology practices. This partnership enables CHO to expand patient-focused services, grow clinical trial offerings, and pursue new market opportunities—while continuing to provide the high-quality, compassionate care that has defined the practice for more than...

 PRESS RELEASE

American Oncology Network Central Lab Receives Reaccreditation from Co...

American Oncology Network Central Lab Receives Reaccreditation from College of American Pathologists FORT MYERS, Fla., July 24, 2025 (GLOBE NEWSWIRE) --  (AON), one of the nation’s fastest-growing networks of community oncology practices, has received reaccreditation from  for its Central Laboratory in Fort Myers, Florida. The recognition follows a recent on-site inspection conducted as part of the CAP’s Accreditation Programs. Recognized for its rigorous standards and commitment to quality, CAP accreditation helps ensure laboratories operate at the highest levels of accuracy and reliabi...

 PRESS RELEASE

More Than 40 American Oncology Network Clinics Across 18 States and Wa...

More Than 40 American Oncology Network Clinics Across 18 States and Washington, D.C., Now Offering Bispecific T-cell Engager Therapies to Patients AON community oncology practices across the nation offering groundbreaking immunotherapy to expand treatment options for hard-to-treat cancers FORT MYERS, Fla., July 22, 2025 (GLOBE NEWSWIRE) --  (AON), one of the nation’s fastest-growing networks of community oncology practices, is now offering Bispecific T-cell Engager (BiTE) therapy—also known as —at more than 40 partner practice clinics in 18 states and Washington, D.C. This advancement b...

 PRESS RELEASE

Auerbach Hematology and Oncology Joins American Oncology Network, Beco...

Auerbach Hematology and Oncology Joins American Oncology Network, Becomes The Center for Cancer and Blood Disorders – Baltimore BALTIMORE, July 15, 2025 (GLOBE NEWSWIRE) -- Auerbach Hematology and Oncology Associates PC, a trusted name in hematology and oncology care in Baltimore, Maryland, is proud to announce it has joined  (AON), one of the nation’s fastest-growing networks of community-based oncology practices. The practice, located at 5233 King Ave., Suite 308, will now be known as . This partnership enables ,  and to expand their patient-focused services, grow clinical trial offer...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch